BlackRock Advisors LLC reduced its stake in shares of Quotient Ltd. (NASDAQ:QTNT) by 2.0% during the second quarter, Holdings Channel reports. The firm owned 714,121 shares of the company’s stock after selling 14,254 shares during the period. BlackRock Advisors LLC owned 4.97% of Quotient worth $5,534,000 at the end of the most recent reporting period.
Other hedge funds and other institutional investors have also bought and sold shares of the company. Ameriprise Financial Inc. raised its position in Quotient by 33.6% in the second quarter. Ameriprise Financial Inc. now owns 599,640 shares of the company’s stock valued at $4,639,000 after buying an additional 150,674 shares during the period. First New York Securities LLC NY acquired a new position in Quotient during the second quarter valued at approximately $140,000. Schonfeld Strategic Advisors LLC acquired a new position in Quotient during the first quarter valued at approximately $172,000. Bellevue Group AG acquired a new position in Quotient during the first quarter valued at approximately $880,000. Finally, Geode Capital Management LLC acquired a new position in Quotient during the first quarter valued at approximately $105,000. 41.50% of the stock is owned by institutional investors and hedge funds.
Quotient Ltd. (NASDAQ:QTNT) opened at 7.62 on Friday. Quotient Ltd. has a 1-year low of $5.67 and a 1-year high of $17.44. The firm’s 50-day moving average is $7.44 and its 200-day moving average is $8.25. The firm’s market capitalization is $109.55 million.
Separately, Zacks Investment Research lowered shares of Quotient from a “hold” rating to a “sell” rating in a research note on Wednesday.
In other news, insider D J. Paul E. Cowan acquired 45,455 shares of Quotient stock in a transaction dated Wednesday, August 3rd. The stock was acquired at an average cost of $5.50 per share, for a total transaction of $250,002.50. Following the completion of the purchase, the insider now owns 26,666 shares of the company’s stock, valued at $146,663. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, Director L John Wilkerson acquired 180,000 shares of Quotient stock in a transaction dated Wednesday, August 3rd. The stock was purchased at an average price of $5.50 per share, with a total value of $990,000.00. The disclosure for this purchase can be found here. 40.50% of the stock is currently owned by insiders.
Quotient Limited is a diagnostics company. The Company focuses on blood grouping and donor disease screening, which is referred to as transfusion diagnostics. It is engaged in developing, manufacturing and commercializing conventional reagent products used for blood grouping within the global transfusion diagnostics market.
Want to see what other hedge funds are holding QTNT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Quotient Ltd. (NASDAQ:QTNT).
Receive News & Ratings for Quotient Ltd. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Quotient Ltd. and related companies with MarketBeat.com's FREE daily email newsletter.